Back
Bioventus Vs. Nukkleus Industry Stock Comparison
Sell
46
BVS
Bioventus
Last Price:
$10.68
Seasonality Move:
-12.86%
Sell
46
NUKK
Nukkleus
Last Price:
$36.44
Seasonality Move:
-19.41%
Sell
46
Bioventus (BVS)
is a Sell
Is Bioventus a Buy, Sell or Hold?
-
BVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUKK Stock Price Chart
BVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 39.47 | Sell |
Chaikin Money Flow: | 301444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.89 - 11.93) | Sell |
Bollinger Bands (100): | (9.39 - 12.63) | Sell |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.75 | Buy |
Relative Strength Index (14 RSI): | 78.03 | Buy |
Chaikin Money Flow: | -1645260 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-7.27 - 25.57) | Buy |
Bollinger Bands (100): | (-4.7 - 12.76) | Buy |
BVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.86 | Sell |
20-day SMA: | 11.39 | Sell |
50-day SMA: | 11.98 | Sell |
200-day SMA: | 8.39 | Buy |
8-day EMA: | 10.86 | Sell |
20-day EMA: | 11.22 | Sell |
50-day EMA: | 11.41 | Sell |
200-day EMA: | 9.07 | Buy |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.1 | Buy |
20-day SMA: | 11 | Buy |
50-day SMA: | 5.78 | Buy |
200-day SMA: | 4.96 | Buy |
8-day EMA: | 29.9 | Buy |
20-day EMA: | 16.84 | Buy |
50-day EMA: | 8.81 | Buy |
200-day EMA: | 12.07 | Buy |
Bioventus Earnings Growth & BVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.22 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bioventus Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |